Sinopharm Group Co's book value per share for the quarter that ended in Dec. 2025 was $19.10.
During the past 12 months, Sinopharm Group Co's average Book Value Per Share Growth Rate was 10.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sinopharm Group Co was 77.30% per year. The lowest was 3.60% per year. And the median was 11.30% per year.
Sinopharm Group Co's current price is $10.88. Its book value per share for the quarter that ended in Dec. 2025 was $19.10. Hence, today's PB Ratio of Sinopharm Group Co is 0.57.
During the past 13 years, the highest P/B Ratio of Sinopharm Group Co was 3.21. The lowest was 0.53. And the median was 0.98.
Good Sign:
Sinopharm Group Co Ltd stock PB Ratio (=0.58) is close to 10-year low of 0.53.
Sinopharm Group Co (OTCPK:SHTDY) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Sinopharm Group Co Book Value per Share Related Terms
Sinopharm Group Co Book Value per Share Historical Data
* Premium members only.
The historical data trend for Sinopharm Group Co's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHTDY vs MCK, CAH, COR: Book Value per Share Comparison
For the Medical Distribution subindustry, Sinopharm Group Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (SHTDY) has a Book Value per Share of $19.10 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Sinopharm Group Co and its competitors.
Is Sinopharm Group Co's Book Value per Share too high?
Sinopharm Group Co's current Book Value per Share is $19.10. Overall, Sinopharm Group Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Group Co's Book Value per Share compare to MCK and CAH?
Sinopharm Group Co's Book Value per Share of $19.10 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Medical Distribution company?
A good Book Value per Share depends on the Medical Distribution industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Sinopharm Group Co and its competitors. Sinopharm Group Co's current Book Value per Share is $19.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Group Co (SHTDY) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.21, compared to a current price of $10.88 — trading 17.6% below its estimated fair value. The current Book Value per Share is $19.10. Sinopharm Group Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Sinopharm Group Co (SHTDY), the current Book Value per Share is $19.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Group Co (SHTDY) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Group Co stock appears to be undervalued.
The current stock price of $10.88 is trading 17.6% below its estimated GF Value™ of $13.21.
GuruFocus considers Sinopharm Group Co to be Modestly Undervalued.
Key valuation signals for SHTDY:
Book Value per Share: $19.10
GF Value™: $13.21 vs. price of $10.88 (17.6% below fair value)
No single metric tells the full story. See the SHTDY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
73GF Score
Get the complete analysis for SHTDY
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTDY has been successfully added to your 
